The Certification Mark as a Necessary but Insufficient Signal
For procurement officers responsible for drinking water treatment equipment, third-party certification marks serve as a first-level filter — evidence that a product has been independently verified to meet a defined performance standard. The NSF/ANSI 53 mark for PFAS reduction is a meaningful signal that a product has been tested, that the test was conducted by an accredited laboratory, and that the product met the effluent concentration threshold for the tested compounds. It is not, however, evidence that the product performs adequately for all PFAS compounds of regulatory or operational concern. Treating it as such is the central procurement error in the current PFAS regulatory environment.
The EPA 2024 MCLs for PFAS cover six individual compounds and a hazard index mixture. The NSF/ANSI 53 certification scope covers two. A procurement process that accepts the NSF 53 PFAS mark as sufficient evidence of regulatory compliance for a facility subject to the 2024 rule has a material gap in its technical documentation. This gap is not a theoretical risk — it is a documented limitation of the current certification standard that NSF itself has acknowledged in public communications about standard revision planning.
Building a Compound-Specific Data Request
A technically complete data request to a filter manufacturer or distributor should specify each compound for which performance documentation is required, the analytical method to be used, and the performance criterion (effluent concentration at rated capacity). For a facility subject to EPA 2024 MCLs, the minimum compound list includes: PFOA (4 ppt MCL), PFOS (4 ppt MCL), PFNA (10 ppt MCL), PFHxS (10 ppt MCL), and HFPO-DA/GenX (10 ppt MCL). For facilities in regions with known short-chain PFAS contamination, PFBS and PFBA should be added to the data request even though individual MCLs for these compounds remain under the hazard index framework.
The analytical method specification matters. Request EPA Method 533 data for ionic PFAS including short-chain compounds, and EPA Method 537.1 for PFOA and PFOS baseline confirmation. If a manufacturer can only provide Method 537.1 data, the short-chain compound profile is simply unmeasured, not zero. KCL test certificates listing compound-specific PFNA and PFHxS data provide the intermediate compound coverage that bridges the NSF 53 scope and the EPA 2024 requirement.
Evaluating Manufacturer Responses to Compound-Specific Requests
When manufacturers respond to compound-specific data requests, the quality of the response itself is informative. A manufacturer with genuine compound-specific test data will provide the actual test report with influent and effluent concentrations for each compound, the challenge matrix specifications, the test duration and service volume, and the accreditation certificate of the testing laboratory. A manufacturer without such data will typically respond with marketing materials referencing the NSF 53 mark, statements that their filter “removes PFAS” without compound specification, or general references to activated carbon or ion exchange mechanisms.
The absence of compound-specific data for PFNA and PFHxS in a manufacturer’s response should be documented and weighted in the procurement evaluation. It does not mean the product fails to remove these compounds — it means performance for these compounds is unverified. For regulated facilities, unverified performance for regulated compounds is not an acceptable foundation for a compliance program.
Incorporating Data Requirements into Procurement Specifications
Procurement specifications for PFAS-removing filter devices should be written to require compound-specific performance data as a threshold criterion rather than a scored evaluation factor. A practical specification structure: (1) Required: NSF/ANSI 53 certification for PFOA and PFOS reduction; (2) Required: Independent third-party test data demonstrating PFNA reduction below 10 ppt from a challenge concentration of at least 100 ppt, using EPA Method 533 or equivalent; (3) Required: Equivalent documentation for PFHxS; (4) Preferred: Method 533 coverage for PFBS, PFHpA, and HFPO-DA. Products not meeting requirements (1) through (3) are disqualified regardless of price or other performance attributes.
This specification structure forces the market toward more complete compound testing and provides procurement officers with a defensible technical basis for product selection. It also creates appropriate competitive pressure on manufacturers to invest in compound-specific certification infrastructure — which is precisely the market signal that will accelerate revision of NSF/ANSI 53 and related standards to cover the full 2024 MCL compound list.